Trial intelligence / Profile preview

Lidocaine Spray vs Oral Viscous for Chemoradiation-Induced Mucositis Pain in Head and Neck Cancer

TCTR20241115007Phase 2Completed

Sponsor
Routine to research
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lidocaine in head and neck cancer (HNC), stomatitis, sponsored by Routine to research. Started May 2023; status: completed.

02

Drugs

lidocaine
03

Conditions

head and neck cancer (HNC)stomatitis

Beyond the preview

Go deeper on TCTR20241115007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20241115007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call